Another research team investigating guanine nucleotide releasing protein 3 (RASGRP3), which encodes the RAS gene, found that mutations in RASGRP3 promote thyroid cancer cell proliferation, migration and invasion, while reducing NIS expression and iodine uptake capacity. The gene discussed is SLC5A5; the disease is thyroid gland carcinoma.